Pila Pharma AB (publ) (STO:PILA)
Sweden · Delayed Price · Currency is SEK 1.212
-0.116 (-8.73%)
Feb 11, 2026, 9:24 AM CET
Pila Pharma AB Market Cap
Pila Pharma AB has a market cap or net worth of 55.89 million as of February 10, 2026. Its market cap has decreased by -46.07% in one year.
Market Cap
55.89M
Enterprise Value
39.99M
Revenue
957.89K
Ranking
n/a
PE Ratio
n/a
Stock Price
1.21
Market Cap Chart
Since July 15, 2021, Pila Pharma AB's market cap has decreased from 144.39M to 55.89M, a decrease of -61.29%. That is a compound annual growth rate of -18.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 55.89M | -35.53% |
| Dec 30, 2025 | 86.69M | -14.78% |
| Dec 30, 2024 | 101.72M | 167.21% |
| Dec 29, 2023 | 38.07M | -23.60% |
| Dec 29, 2022 | 49.83M | -54.49% |
| Dec 30, 2021 | 109.48M | -24.17% |
| Jul 15, 2021 | 144.39M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alligator Bioscience AB | 96.21M |
| Spago Nanomedical AB | 83.03M |
| Scandinavian ChemoTech AB | 82.87M |
| Alzinova AB | 73.97M |
| OncoZenge AB | 70.57M |
| ExpreS2ion Biotech Holding AB | 54.65M |
| 2cureX AB | 48.95M |
| AcouSort AB | 47.41M |